1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NPIPA7 CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA YTHDF2 CTRPv2 pan-cancer AAC 0.13 6e-05
mRNA HIST2H4A CTRPv2 pan-cancer AAC -0.13 6e-05
mRNA NNMT CTRPv2 pan-cancer AAC -0.15 6e-05
mRNA GPR39 CTRPv2 pan-cancer AAC -0.15 6e-05
mRNA LYSMD3 CTRPv2 pan-cancer AAC -0.13 6e-05
mRNA FKBP6 CTRPv2 pan-cancer AAC 0.13 6e-05
mRNA MTR CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA ZSCAN2 CTRPv2 pan-cancer AAC 0.14 6e-05
mRNA KIAA0895 CTRPv2 pan-cancer AAC 0.14 6e-05
Download CSV